ORAI1 and Duchenne muscular dystrophy: These results demonstrate an important role of enhanced Orai1-mediated Ca2+ entry in exacerbating the dystrophic phenotype of mdx mice, rendering Orai1 an attractive potential therapeutic target for the treatment of DMD.